Bridge Biotherapeutics, Inc. is a virtually-operated, venture-backed clinical stage global biotech company, headquartered in Seongnam, Korea with its subsidiary at JLABS@TMC, engaged in the development of novel therapeutics, focusing on therapeutic areas of high unmet medical needs, such as ulcerative colitis, fibrotic diseases, and cancers.

Biotechnology

Health Care

Bridge Biotherapeutics, Inc.

James Jungkue Lee

Hyung Eun Kim

JJ Lim 임종진

Joengbin Ahn

진혁 정

Yunseon Chong

The Clinical and Scientific Affairs team at Bridge Biotherapeutics, Inc. oversees the strategic planning and execution of clinical trials, ensuring they align with scientific goals and regulatory standards. The team is responsible for coordinating interdisciplinary research to advance the development of novel therapeutics, driving scientific innovation, and managing clinical operations to address high unmet medical needs in areas such as ulcerative colitis, fibrotic diseases, and cancers.

Clinical and Scientific Affairs

The Leadership Team at Bridge Biotherapeutics, Inc. is responsible for setting the strategic direction, overseeing clinical development, and driving innovative research to advance the company's pipeline of novel therapeutics. The team ensures alignment across key operational areas and fosters partnerships to address high unmet medical needs in therapeutic areas such as ulcerative colitis, fibrotic diseases, and cancers.

Bridge Biotherapeutics, Inc.

Org chart

Teams

Clinical and Scientific Affairs

Leadership Team

Offices

Bridge Biotherapeutics, Inc.

Org chart

Teams

Clinical and Scientific Affairs

Leadership Team

Offices

Related companies